We are live on
!
Find out more
CIA
Capital Impact Advisors Portfolio holdings
AUM
$247M
1-Year Est. Return
31.15%
This Fund
S&P 500
This Quarter
Est. Return
+10.5%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$124M
AUM Growth
–
Cap. Flow
+$119M
Cap. Flow
% of AUM
95.59%
Top 10 Holdings %
Top 10 Hldgs %
15.12%
Holding
93
New
93
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
|
+$1.82M |
| 2 |
LL
LL Flooring Holdings, Inc.
LL
|
+$1.8M |
| 3 |
PRA Group
PRAA
|
+$1.76M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$1.75M |
| 5 |
Myriad Genetics
MYGN
|
+$1.72M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.42% |
| 2 | Consumer Discretionary | 19.74% |
| 3 | Financials | 14.44% |
| 4 | Healthcare | 10.65% |
| 5 | Consumer Staples | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ambarella
AMBA
$2.88B
| $2.19M | 1.76% |
+64,699
| New | +$1.48M |
|
2
United Therapeutics
UTHR
$22.5B
| $2.05M | 1.64% |
+18,091
| New | +$1.63M |
|
|
HCR
3
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $2.01M | 1.61% |
+52,895
| New | +$1.67M |
|
4
HCI Group
HCI
$2.29B
| $1.87M | 1.5% |
+34,896
| New | +$1.6M |
|
5
Oracle
ORCL
$350B
| $1.82M | 1.47% |
+47,704
| New | +$1.64M |
|
6
Meritage Homes
MTH
$4.75B
| $1.82M | 1.46% |
+75,992
| New | +$1.65M |
|
7
Jazz Pharmaceuticals
JAZZ
$15.3B
| $1.8M | 1.45% |
+14,262
| New | +$1.48M |
|
|
ABAX
8
DELISTED
Abaxis Inc
ABAX
| $1.75M | 1.41% |
+43,871
| New | +$1.62M |
|
9
Hain Celestial
HAIN
$47.8M
| $1.75M | 1.41% |
+38,624
| New | +$1.6M |
|
|
LL
10
DELISTED
LL Flooring Holdings, Inc.
LL
| $1.74M | 1.4% |
+16,947
| New | +$1.8M |
|
|
PRXL
11
DELISTED
Parexel International Corp
PRXL
| $1.73M | 1.39% |
+38,323
| New | +$1.75M |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.72M | 1.38% |
+12,926
| New | +$1.55M |
|
|
TFCFA
13
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $1.71M | 1.38% |
+48,721
| New | +$1.64M |
|
14
Capital One
COF
$127B
| $1.7M | 1.36% |
+22,167
| New | +$1.58M |
|
|
SNDK
15
DELISTED
SANDISK CORP
SNDK
| $1.69M | 1.35% |
+23,891
| New | +$1.61M |
|
16
Papa John's
PZZA
$1.1B
| $1.68M | 1.35% |
+36,956
| New | +$1.48M |
|
17
IPG Photonics
IPGP
$4.16B
| $1.67M | 1.34% |
+21,526
| New | +$1.46M |
|
|
OVTI
18
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $1.66M | 1.33% |
+96,386
| New | +$1.46M |
|
19
VeriSign
VRSN
$25.3B
| $1.66M | 1.33% |
+27,701
| New | +$1.53M |
|
20
Interparfums
IPAR
$3.98B
| $1.65M | 1.33% |
+46,043
| New | +$1.58M |
|
21
Urban Outfitters
URBN
$6.41B
| $1.65M | 1.32% |
+44,407
| New | +$1.66M |
|
|
PNRA
22
DELISTED
Panera Bread Co
PNRA
| $1.65M | 1.32% |
+9,320
| New | +$1.56M |
|
23
Evercore
EVR
$12.9B
| $1.64M | 1.32% |
+27,506
| New | +$1.46M |
|
|
CERN
24
DELISTED
Cerner Corp
CERN
| $1.64M | 1.32% |
+29,455
| New | +$1.65M |
|
25
Starbucks
SBUX
$119B
| $1.64M | 1.32% |
+41,852
| New | +$1.66M |
|
Similar funds
EPW
MHWM
AI
NF
AB
ACA
PWS
BFM
Capital Impact Advisors's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Capital Impact Advisors, which disclosed 93 positions worth $124M. Its ten largest holdings account for 15% of the portfolio.
Its largest position is BIO-REFERENCE LABS INC-NEW-: 59,193 shares worth $1.51M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, followed by Consumer Discretionary and Financials.
- Capital Impact Advisors's largest Q4 2013 buy was BIO-REFERENCE LABS INC-NEW-: 59,193 shares worth $1.51M.
- Capital Impact Advisors's ten largest holdings make up 15% of its $124M portfolio in Q4 2013.
- Capital Impact Advisors disclosed 93 positions in Q4 2013, its first 13F filing on record.
Based on Capital Impact Advisors's 13F filing for Q4 2013, filed 13 Mar 2014.